A Prospective Multicenter Trial Evaluating Diagnostic Validity of Multivariate Analysis and Individual Serum Marker in Differential Diagnosis of Pancreatic Cancer from Benign Pancreatic Diseases
- 1 January 1999
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 25 (1) , 23-30
- https://doi.org/10.1385/ijgc:25:1:23
Abstract
Conclusion: A multivariate analysis of CAMPAS-PX2 can increase its diagnostic accuracy in differential diagnosis of pancreatic cancer from benign pancreatic or extrapancreatic disease, when compared...Keywords
This publication has 12 references indexed in Scilit:
- Effectiveness of Multivariate Analysis of Tumor Markers in Diagnosis of Pancreatic CarcinomaPancreas, 1994
- Differential diagnosis of pancreatic diseases with an intraductal ultrasound systemGastrointestinal Endoscopy, 1994
- Clinical usefulness of computer-assisted diagnosis using combination assay of tumor markers for pancreatic carcinomaCancer, 1993
- Prospective trial for early detection of pancreatic cancer by elevated serum immunoreactive elastaseGastroenterologia Japonica, 1990
- The clinical utility of the CA 19-9 tumor-associated antigen.1990
- Usefulness of a new tumor marker, span-1, for the diagnosis of pancreatic cancerCancer, 1990
- The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer: A prospective study of 866 patientsCancer, 1988
- Sensitive serum markers for detecting pancreatic cancerCancer, 1988
- Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19‐9International Journal of Cancer, 1987
- Serum immunoreactive elastase in diagnosis of pancreatic diseasesDigestive Diseases and Sciences, 1987